Serum C-reactive protein as a prognostic factor in patients with epithelial ovarian cancer

Junichi Kodama, Yasunari Miyagi, Noriko Seki, Keizo Tokumo, Yoshinouchi Mitsuo Yoshinouchi, Yuuji Kobashi, Hiroyuki Okuda, Takafumi Kudo

Research output: Contribution to journalArticle

65 Citations (Scopus)

Abstract

Objective: It is well known that the serum level of Interleukin-6 (IL-6) correlates with the level of C-reactive protein (CRP). The purpose of this study is to determine the significance of CRP as a prognostic factor in epithelial ovarian cancer. Study Design: The present study is comprised of 120 patients with epithelial ovarian cancer from 1985 to 1992. In this study, CRP levels above 50 mg/l were considered high CRP. Univariate and multivariate analyses were performed to identify clinicopathological variables associated with poor survival. Results: The serum CRP value was significantly associated with the volume of ascites (P=0.000004). Univariate analysis showed that the FIGO stage, primary tumour diameter, size of residual tumour, histologic grade, volume of ascites and high serum level of CRP were significant prognostic factors. Cox's multivariate proportional hazard model showed that histologic grade was the most important prognostic factor (P=0.0026). FIGO stage and volume of ascites were also independent factors for 5-year survival (P=0.0310 and P=0.0216, respectively). However, the serum CRP value was not an independent prognostic factor. Conclusion: CRP is an adverse prognostic factor in univariate analysis, but not in multivariate analysis. Copyright (C) 1999 Elsevier Science Ltd.

Original languageEnglish
Pages (from-to)107-110
Number of pages4
JournalEuropean Journal of Obstetrics Gynecology and Reproductive Biology
Volume82
Issue number1
DOIs
Publication statusPublished - Jan 1 1999

Fingerprint

C-Reactive Protein
Blood Proteins
Ascites
Multivariate Analysis
Survival
Ovarian epithelial cancer
Residual Neoplasm
Serum
Proportional Hazards Models
Interleukin-6
Neoplasms

Keywords

  • C-reactive protein
  • Epithelial ovarian cancer
  • Prognostic factor

ASJC Scopus subject areas

  • Obstetrics and Gynaecology
  • Reproductive Medicine

Cite this

Serum C-reactive protein as a prognostic factor in patients with epithelial ovarian cancer. / Kodama, Junichi; Miyagi, Yasunari; Seki, Noriko; Tokumo, Keizo; Mitsuo Yoshinouchi, Yoshinouchi; Kobashi, Yuuji; Okuda, Hiroyuki; Kudo, Takafumi.

In: European Journal of Obstetrics Gynecology and Reproductive Biology, Vol. 82, No. 1, 01.01.1999, p. 107-110.

Research output: Contribution to journalArticle

Kodama, J, Miyagi, Y, Seki, N, Tokumo, K, Mitsuo Yoshinouchi, Y, Kobashi, Y, Okuda, H & Kudo, T 1999, 'Serum C-reactive protein as a prognostic factor in patients with epithelial ovarian cancer', European Journal of Obstetrics Gynecology and Reproductive Biology, vol. 82, no. 1, pp. 107-110. https://doi.org/10.1016/S0301-2115(98)00227-9
Kodama, Junichi ; Miyagi, Yasunari ; Seki, Noriko ; Tokumo, Keizo ; Mitsuo Yoshinouchi, Yoshinouchi ; Kobashi, Yuuji ; Okuda, Hiroyuki ; Kudo, Takafumi. / Serum C-reactive protein as a prognostic factor in patients with epithelial ovarian cancer. In: European Journal of Obstetrics Gynecology and Reproductive Biology. 1999 ; Vol. 82, No. 1. pp. 107-110.
@article{633177f39a5a4fd8892c00223aa044d9,
title = "Serum C-reactive protein as a prognostic factor in patients with epithelial ovarian cancer",
abstract = "Objective: It is well known that the serum level of Interleukin-6 (IL-6) correlates with the level of C-reactive protein (CRP). The purpose of this study is to determine the significance of CRP as a prognostic factor in epithelial ovarian cancer. Study Design: The present study is comprised of 120 patients with epithelial ovarian cancer from 1985 to 1992. In this study, CRP levels above 50 mg/l were considered high CRP. Univariate and multivariate analyses were performed to identify clinicopathological variables associated with poor survival. Results: The serum CRP value was significantly associated with the volume of ascites (P=0.000004). Univariate analysis showed that the FIGO stage, primary tumour diameter, size of residual tumour, histologic grade, volume of ascites and high serum level of CRP were significant prognostic factors. Cox's multivariate proportional hazard model showed that histologic grade was the most important prognostic factor (P=0.0026). FIGO stage and volume of ascites were also independent factors for 5-year survival (P=0.0310 and P=0.0216, respectively). However, the serum CRP value was not an independent prognostic factor. Conclusion: CRP is an adverse prognostic factor in univariate analysis, but not in multivariate analysis. Copyright (C) 1999 Elsevier Science Ltd.",
keywords = "C-reactive protein, Epithelial ovarian cancer, Prognostic factor",
author = "Junichi Kodama and Yasunari Miyagi and Noriko Seki and Keizo Tokumo and {Mitsuo Yoshinouchi}, Yoshinouchi and Yuuji Kobashi and Hiroyuki Okuda and Takafumi Kudo",
year = "1999",
month = "1",
day = "1",
doi = "10.1016/S0301-2115(98)00227-9",
language = "English",
volume = "82",
pages = "107--110",
journal = "European Journal of Obstetrics and Gynecology and Reproductive Biology",
issn = "0028-2243",
publisher = "Elsevier Ireland Ltd",
number = "1",

}

TY - JOUR

T1 - Serum C-reactive protein as a prognostic factor in patients with epithelial ovarian cancer

AU - Kodama, Junichi

AU - Miyagi, Yasunari

AU - Seki, Noriko

AU - Tokumo, Keizo

AU - Mitsuo Yoshinouchi, Yoshinouchi

AU - Kobashi, Yuuji

AU - Okuda, Hiroyuki

AU - Kudo, Takafumi

PY - 1999/1/1

Y1 - 1999/1/1

N2 - Objective: It is well known that the serum level of Interleukin-6 (IL-6) correlates with the level of C-reactive protein (CRP). The purpose of this study is to determine the significance of CRP as a prognostic factor in epithelial ovarian cancer. Study Design: The present study is comprised of 120 patients with epithelial ovarian cancer from 1985 to 1992. In this study, CRP levels above 50 mg/l were considered high CRP. Univariate and multivariate analyses were performed to identify clinicopathological variables associated with poor survival. Results: The serum CRP value was significantly associated with the volume of ascites (P=0.000004). Univariate analysis showed that the FIGO stage, primary tumour diameter, size of residual tumour, histologic grade, volume of ascites and high serum level of CRP were significant prognostic factors. Cox's multivariate proportional hazard model showed that histologic grade was the most important prognostic factor (P=0.0026). FIGO stage and volume of ascites were also independent factors for 5-year survival (P=0.0310 and P=0.0216, respectively). However, the serum CRP value was not an independent prognostic factor. Conclusion: CRP is an adverse prognostic factor in univariate analysis, but not in multivariate analysis. Copyright (C) 1999 Elsevier Science Ltd.

AB - Objective: It is well known that the serum level of Interleukin-6 (IL-6) correlates with the level of C-reactive protein (CRP). The purpose of this study is to determine the significance of CRP as a prognostic factor in epithelial ovarian cancer. Study Design: The present study is comprised of 120 patients with epithelial ovarian cancer from 1985 to 1992. In this study, CRP levels above 50 mg/l were considered high CRP. Univariate and multivariate analyses were performed to identify clinicopathological variables associated with poor survival. Results: The serum CRP value was significantly associated with the volume of ascites (P=0.000004). Univariate analysis showed that the FIGO stage, primary tumour diameter, size of residual tumour, histologic grade, volume of ascites and high serum level of CRP were significant prognostic factors. Cox's multivariate proportional hazard model showed that histologic grade was the most important prognostic factor (P=0.0026). FIGO stage and volume of ascites were also independent factors for 5-year survival (P=0.0310 and P=0.0216, respectively). However, the serum CRP value was not an independent prognostic factor. Conclusion: CRP is an adverse prognostic factor in univariate analysis, but not in multivariate analysis. Copyright (C) 1999 Elsevier Science Ltd.

KW - C-reactive protein

KW - Epithelial ovarian cancer

KW - Prognostic factor

UR - http://www.scopus.com/inward/record.url?scp=0032894141&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032894141&partnerID=8YFLogxK

U2 - 10.1016/S0301-2115(98)00227-9

DO - 10.1016/S0301-2115(98)00227-9

M3 - Article

C2 - 10192497

AN - SCOPUS:0032894141

VL - 82

SP - 107

EP - 110

JO - European Journal of Obstetrics and Gynecology and Reproductive Biology

JF - European Journal of Obstetrics and Gynecology and Reproductive Biology

SN - 0028-2243

IS - 1

ER -